Pharmaceutical compositions

Details for Australian Patent Application No. 2005299829 (hide)

Owner Exelixis, Inc.

Inventors Stevens, William C. Jr.; Mohan, Raju; Martin, Richard; Busch, Brett B.; Nyman, Michael Charles

Agent Davies Collison Cave

Pub. Number AU-B-2005299829

PCT Pub. Number WO2006/047269

Priority 60/621,296 22.10.04 US

Filing date 21 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 8 September 2011

International Classifications

C07D 277/54 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/401 (2006.01) - Proline

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/047269 Priority application(s): WO2006/047269

8 September 2011 Application Accepted

  Published as AU-B-2005299829

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299831-Membrane based electrochemical cell stacks

2005299822-4 [(2,4-dichloro-5-methoxyphenyl)amino]- 6-alkoxy-7-ethynyl-3-quinolinecarbonitril es for the treatment of ischemic injury